Stryker Corporation (SYK) Key Metrics
SYK valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $113.02B
- Enterprise value
- $116.98B
- P/E (TTM)
- 30.5 10-yr median 40.5
- Forward P/E
- 16.5
- PEG ratio
- 1.29
- Price / sales
- 4.4 10-yr median 5.4
- Price / book
- 4.4 10-yr median 6.1
- EV / EBITDA
- 16.8 10-yr median 24.3
- Dividend yield
- 1.19% $3.52 a year
- Beta
- 0.78
SYK key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsSYK valuation Price multiples at each fiscal year-end price.
SYK returns How much profit the business earns on the capital it uses.
SYK per-share figures Results divided by the shares outstanding at year-end.
SYK financial health Debt, liquidity and how easily interest is covered.
SYK efficiency & capital use Working capital cycle and where the cash goes.
SYK valuation history
SYK returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
SYK debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
SYK cash returned to shareholders
SYK price vs earnings per share
SYK key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $134.33B | $138.84B | $114.90B | $93.44B | $102.23B | $93.19B | $79.76B | $59.61B | $58.85B | $45.35B |
| Enterprise value | $146.59B | $148.55B | $125.34B | $105.04B | $111.69B | $104.16B | $86.42B | $65.77B | $63.28B | $48.88B |
| P/E ratio | 41.4 | 46.4 | 36.3 | 39.6 | 51.3 | 58.3 | 38.3 | 16.8 | 57.7 | 27.5 |
| Price / sales | 5.3 | 6.1 | 5.6 | 5.1 | 6.0 | 6.5 | 5.4 | 4.4 | 4.7 | 4.0 |
| Price / book | 6.0 | 6.7 | 6.2 | 5.6 | 6.9 | 7.1 | 6.2 | 5.1 | 5.9 | 4.7 |
| Price / free cash flow | 31.4 | 39.8 | 36.6 | 45.9 | 37.3 | 33.4 | 51.7 | 29.3 | 61.2 | 31.8 |
| Price / operating cash flow | 26.6 | 32.7 | 31.0 | 35.6 | 31.3 | 28.4 | 36.4 | 22.8 | 37.8 | 23.7 |
| EV / sales | 5.8 | 6.6 | 6.1 | 5.7 | 6.5 | 7.3 | 5.8 | 4.8 | 5.1 | 4.3 |
| EV / EBITDA | 23.2 | 24.7 | 24.8 | 26.1 | 31.0 | 33.8 | 23.8 | 19.7 | 21.4 | 18.1 |
| EV / free cash flow | 34.2 | 42.6 | 40.0 | 51.6 | 40.8 | 37.3 | 56.0 | 32.3 | 65.9 | 34.3 |
| Earnings yield | 2.4% | 2.2% | 2.8% | 2.5% | 2.0% | 1.7% | 2.6% | 6.0% | 1.7% | 3.6% |
| Free cash flow yield | 3.2% | 2.5% | 2.7% | 2.2% | 2.7% | 3.0% | 1.9% | 3.4% | 1.6% | 3.1% |
| Dividend yield | 1.0% | 0.9% | 1.0% | 1.1% | 0.9% | 0.9% | 1.0% | 1.2% | 1.1% | 1.3% |
| Shareholder yield (dividends + buybacks) | 1.1% | 1.0% | 1.1% | 1.3% | 1.0% | 1.0% | 1.4% | 1.7% | 1.5% | 1.3% |
| Share price at fiscal year-end | $351.47 | $360.05 | $299.46 | $244.49 | $267.42 | $245.04 | $209.94 | $156.75 | $154.84 | $119.81 |
| Per share | ||||||||||
| Revenue per share | $65.71 | $58.60 | $53.42 | $48.27 | $44.75 | $37.74 | $39.18 | $35.76 | $32.74 | $29.92 |
| Earnings per share | $8.49 | $7.76 | $8.25 | $6.17 | $5.22 | $4.20 | $5.48 | $9.34 | $2.68 | $4.35 |
| Operating cash flow per share | $13.20 | $11.00 | $9.67 | $6.87 | $8.54 | $8.62 | $5.77 | $6.86 | $4.10 | $5.06 |
| Free cash flow per share | $11.21 | $9.04 | $8.17 | $5.33 | $7.16 | $7.34 | $4.06 | $5.36 | $2.53 | $3.76 |
| Cash per share | $10.73 | $11.42 | $7.96 | $5.04 | $7.90 | $7.95 | $11.65 | $9.73 | $7.35 | $8.94 |
| Book value per share | $58.66 | $53.51 | $48.46 | $43.47 | $38.91 | $34.40 | $33.71 | $30.84 | $26.29 | $25.23 |
| Tangible book value per share | −$6.68 | $1.00 | −$3.24 | −$8.24 | −$7.54 | −$13.80 | −$1.29 | −$2.62 | −$1.71 | −$0.83 |
| Dividends per share | $3.36 | $3.16 | $2.97 | $2.75 | $2.48 | $2.27 | $2.05 | $1.85 | $1.67 | $1.50 |
| Capex per share | $1.99 | $1.96 | $1.50 | $1.54 | $1.37 | $1.28 | $1.71 | $1.50 | $1.57 | $1.29 |
| Debt per share | $42.80 | $36.62 | $35.17 | $35.39 | $32.64 | $36.79 | $29.19 | $25.92 | $19.00 | $18.27 |
| Shares outstanding | 382.2M | 385.6M | 383.7M | 382.2M | 382.3M | 380.3M | 379.9M | 380.3M | 380.1M | 378.5M |
| Change in shares outstanding | −0.9% | +0.5% | +0.4% | −0.0% | +0.5% | +0.1% | −0.1% | +0.1% | +0.4% | −0.6% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 15.1% | 15.3% | 18.0% | 15.0% | 14.3% | 12.4% | 17.0% | 32.7% | 10.4% | 18.2% |
| Return on invested capital (ROIC) | 10.8% | 10.6% | 12.9% | 12.5% | 13.6% | 11.4% | 14.7% | 19.2% | 10.1% | 20.5% |
| Return on assets (ROA) | 7.1% | 7.2% | 8.2% | 6.6% | 5.8% | 5.0% | 7.3% | 14.4% | 4.8% | 9.0% |
| Return on tangible assets | 14.2% | 13.2% | 15.8% | 13.8% | 11.8% | 10.0% | 12.3% | 24.5% | 8.8% | 15.6% |
| Free cash flow margin | 17.1% | 15.4% | 15.3% | 11.0% | 16.0% | 19.4% | 10.4% | 15.0% | 7.7% | 12.6% |
| Income quality (OCF / net income) | 1.55 | 1.42 | 1.17 | 1.11 | 1.64 | 2.05 | 1.05 | 0.73 | 1.53 | 1.16 |
| Financial health | ||||||||||
| Total debt | $16.36B | $14.12B | $13.49B | $13.53B | $12.48B | $13.99B | $11.09B | $9.86B | $7.22B | $6.91B |
| Cash & short-term investments | $4.10B | $4.40B | $3.05B | $1.93B | $3.02B | $3.02B | $4.42B | $3.70B | $2.79B | $3.38B |
| Net debt | $12.26B | $9.72B | $10.44B | $11.60B | $9.46B | $10.97B | $6.67B | $6.16B | $4.43B | $3.53B |
| Debt / equity | 0.73 | 0.68 | 0.73 | 0.81 | 0.84 | 1.07 | 0.87 | 0.84 | 0.72 | 0.72 |
| Debt / assets | 0.34 | 0.33 | 0.34 | 0.37 | 0.36 | 0.41 | 0.37 | 0.36 | 0.33 | 0.34 |
| Net debt / EBITDA | 1.94 | 1.62 | 2.06 | 2.89 | 2.62 | 3.56 | 1.84 | 1.84 | 1.50 | 1.31 |
| Current ratio | 1.89 | 1.95 | 1.58 | 1.63 | 2.20 | 1.93 | 2.58 | 2.02 | 2.43 | 3.08 |
| Quick ratio | 1.21 | 1.32 | 0.97 | 1.00 | 1.47 | 1.23 | 1.84 | 1.41 | 1.68 | 2.28 |
| Interest coverage | 8.1 | 9.3 | 12.0 | 11.1 | 11.2 | 9.6 | 11.8 | 11.8 | 11.2 | 11.3 |
| Working capital | $6.96B | $7.23B | $4.60B | $3.97B | $5.47B | $4.67B | $6.96B | $4.93B | $4.70B | $5.31B |
| Invested capital | $34.68B | $30.35B | $29.03B | $28.21B | $24.34B | $24.05B | $19.47B | $17.89B | $14.42B | $13.08B |
| Tangible asset value | −$2.55B | $384.0M | −$1.24B | −$3.15B | −$2.88B | −$5.25B | −$489.0M | −$996.0M | −$651.0M | −$314.0M |
| Net current asset value | −$10.67B | −$7.49B | −$8.80B | −$9.99B | −$9.74B | −$11.54B | −$6.00B | −$5.77B | −$4.20B | −$3.02B |
| Graham number | $105.87 | $96.67 | $94.83 | $77.68 | $67.58 | $57.05 | $64.49 | $80.52 | $39.84 | $49.70 |
| Graham net-net per share | −$40.92 | −$32.57 | −$33.93 | −$35.76 | −$33.51 | −$37.99 | −$24.02 | −$22.54 | −$17.14 | −$13.24 |
| Capital allocation | ||||||||||
| Dividends paid | $1.28B | $1.22B | $1.14B | $1.05B | $950.0M | $863.0M | $778.0M | $703.0M | $636.0M | $568.0M |
| Share buybacks (net) | $149.0M | $195.0M | $155.0M | $122.0M | $114.0M | $110.0M | $307.0M | $300.0M | $230.0M | $13.0M |
| Dividend payout ratio | 39.6% | 40.7% | 36.0% | 44.6% | 47.6% | 54.0% | 37.3% | 19.8% | 62.4% | 34.5% |
| Dividends + buybacks / free cash flow | 33.5% | 40.6% | 41.3% | 57.6% | 38.9% | 34.9% | 70.4% | 49.2% | 90.1% | 40.8% |
| Capex / revenue | 3.0% | 3.3% | 2.8% | 3.2% | 3.1% | 3.4% | 4.4% | 4.2% | 4.8% | 4.3% |
| Capex / operating cash flow | 15.1% | 17.8% | 15.5% | 22.4% | 16.1% | 14.9% | 29.6% | 21.9% | 38.4% | 25.6% |
| Capex / depreciation | 0.64 | 0.72 | 0.56 | 0.59 | 0.53 | 0.60 | 0.83 | 0.79 | 0.93 | 0.90 |
| Stock-based compensation / revenue | 1.0% | 1.0% | 1.0% | 0.9% | 1.0% | 1.0% | 0.9% | 0.9% | 0.9% | 0.9% |
| R&D / revenue | 6.3% | 6.5% | 6.3% | 6.7% | 6.6% | 6.3% | 6.5% | 6.3% | 6.3% | 6.3% |
| SG&A / revenue | 32.7% | 34.0% | 34.8% | 32.7% | 33.6% | 37.4% | 36.0% | 37.5% | 36.6% | 36.5% |
| Efficiency | ||||||||||
| Days sales outstanding | 58.3 | 62.6 | 65.3 | 65.2 | 61.1 | 71.1 | 64.1 | 60.8 | 61.1 | 58.5 |
| Days of inventory on hand | 203.3 | 218.0 | 201.5 | 180.0 | 194.2 | 220.9 | 206.9 | 197.8 | 180.7 | 164.2 |
| Days payables outstanding | 70.1 | 72.5 | 66.8 | 62.6 | 55.3 | 48.4 | 43.8 | 41.3 | 37.1 | 37.9 |
| Cash conversion cycle (days) | 191.5 | 208.2 | 200.0 | 182.6 | 199.9 | 243.6 | 227.1 | 217.2 | 204.6 | 184.7 |
| Receivables turnover | 6.26 | 5.83 | 5.59 | 5.60 | 5.98 | 5.13 | 5.70 | 6.00 | 5.98 | 6.24 |
| Payables turnover | 5.20 | 5.04 | 5.46 | 5.83 | 6.60 | 7.54 | 8.33 | 8.83 | 9.83 | 9.63 |
| Inventory turnover | 1.80 | 1.67 | 1.81 | 2.03 | 1.88 | 1.65 | 1.76 | 1.85 | 2.02 | 2.22 |
| Asset turnover | 0.55 | 0.55 | 0.53 | 0.52 | 0.50 | 0.45 | 0.52 | 0.55 | 0.58 | 0.62 |
| Average receivables | $4.01B | $3.88B | $3.67B | $3.29B | $2.86B | $2.80B | $2.61B | $2.27B | $2.08B | $1.81B |
| Average payables | $1.74B | $1.60B | $1.47B | $1.27B | $969.5M | $742.5M | $660.5M | $566.5M | $462.0M | $423.5M |
| Average inventory | $5.04B | $4.81B | $4.42B | $3.65B | $3.40B | $3.39B | $3.12B | $2.71B | $2.25B | $1.83B |
| Intangibles / total assets | 52.2% | 47.1% | 49.7% | 53.6% | 51.3% | 53.4% | 44.1% | 46.7% | 48.0% | 48.3% |
Computed from SYK's annual financial statements (latest annual report filed February 11, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
SYK valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Stryker traded at 41.4 times earnings, against a 10-year median of 40.5. Based on the latest twelve months, the trailing P/E is 30.5 and the forward P/E is 16.5. Stryker earned a return on equity of 15.1% and a return on invested capital of 10.8% in fiscal 2025. It ended the year with $16.4 billion of debt and $4.1 billion in cash and short-term investments, net debt of $12.3 billion. It returned $1.4 billion to shareholders: $1.3 billion in dividends and $149.0 million in share buybacks, 33% of free cash flow.
See the SYK income statement, the SYK chart for price history, or the SYK stock overview for the latest quote and news.
SYK key metrics FAQ
What is Stryker's P/E ratio?
Stryker's trailing P/E ratio is 30.5 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 16.5. At the end of fiscal 2025 it was 41.4, compared with a 10-year median of 40.5.
What is Stryker's EV/EBITDA?
Stryker's enterprise value was 23.2 times EBITDA at the end of fiscal 2025 (enterprise value $146.6 billion, EBITDA $6.3 billion); the current EV/EBITDA is 16.8.
What is Stryker's return on equity?
Stryker's return on equity (ROE) was 15.1% in fiscal 2025: net income of $3.2 billion on average shareholders' equity of $21.5 billion.
What is Stryker's ROIC?
Stryker's return on invested capital was 10.8% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Stryker have?
Stryker had total debt of $16.4 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.73 and $12.3 billion of net debt (1.94 times EBITDA).
What is Stryker's dividend yield?
Stryker's forward dividend yield is 1.19%. Stryker paid $1.3 billion in dividends in fiscal 2025 ($3.36 per share), a payout ratio of 39.6%.
Does Stryker buy back its shares?
Yes. Stryker spent $149.0 million on net share repurchases in fiscal 2025 Shares outstanding changed −0.9% over the year, to 382.2M..
What is Stryker's free cash flow yield?
Stryker generated $4.3 billion of free cash flow in fiscal 2025, a free cash flow yield of 3.2% on its market value at year-end ($134.3 billion).
What is Stryker's current ratio?
Stryker's current ratio was 1.89 at the end of fiscal 2025: current assets were 1.89 times current liabilities.